Pharmaceutical Freeze Drying Technology
8th & 9th May 2017, London UK
Robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining product quality and biological stability.
Innovation and efficiency is requested at every level making Pharmaceutical Freeze Drying Technology the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to growing manufacturing demands.
Gathering a room of Senior Scientists and Heads of Pharmaceutical Engineering, the 5th annual show provides an ideal forum to discuss the latest advancements in pharmaceutical lyophilisation, welcoming regulatory guidance from the NIBSC-MHRA and expertise from the likes of Sanofi, Boehringer Ingelheim, Roche, Novo Nordisk and more!
• Bakul Bhatnagar, Senior Principal Scientist Bio Therapeutics R&D, Pfizer
• Sune Klint Andersen, Principal Scientist, Novo Nordisk
• Jean-René Authelin, Global Head of Pharmaceutical, Engineering, Sanofi
• Pierre Goldbach, Pharmaceutical Development and Supplies, Roche
• Paul Matejtschuk, Principle Scientist, NIBSC - MHRA
• Mahammad Ahmed, Associate Scientist II, Medimmune
• Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim
• Christoph Korpus, Laboratory Head, Merck
• Xiaodong Chen, Senior Research Investigator, Bristol-Myers Squibb
REASONS TO ATTEND:
• Sanofi , Pfizer and GSK discuss the key to securing successful scale-up in lyophilisation
• Hear about innovations in freeze drying processes and technology
• Tackle challenges in freeze-drying high concentration biologics
• An update on collapsed freeze drying and spray drying as alternative approaches to conventional batch freeze drying
• New approaches to PAT and QbD principles
• Exciting insight into current and future developments in continuous manufacturing
For more information visit http://www.pharmafreezedrying.com/farmavita